Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G
Human respiratory syncytial virus (RSV) poses a significant human health threat, particularly to infants and the elderly.While efficacious vaccines based on the F protein have recently received market authorization, uncertainties remain regarding the future need for vaccine updates to counteract potential viral drift.The attachment protein G has lo